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OBJECTIVES The purposes of this study were to analyze coronary specimens from patients with diabetes
mellitus (DM) and to compare them with specimens from patients without DM.
BACKGROUND Diabetes mellitus is associated with an increased incidence of restenosis after percutaneous
transluminal coronary angioplasty (PTCA). Increased hypercellular smooth muscle cell
proliferation with exaggerated intimal hyperplasia formation may be responsible for this
predisposition.
METHODS Eighteen coronary atherectomy specimens with restenosis after PTCA from patients with
DM were compared with 18 coronary atherectomy specimens with restenosis after PTCA
from patients without DM. Total and segmental areas were quantified on trichrome-stained
tissue of hypercellular tissue, collagen-rich sclerotic tissue, atheroma and thrombus. Demo-
graphic and angiographic data were similar in both groups.
RESULTS The percentage of total plaque area composed of hypercellular tissue was lower in restenotic
specimens from patients with DM than in restenotic specimens from patients without DM
(19 6 6% vs. 44 6 5%; p 5 0.003). The percentage of collagen-rich sclerotic tissue area was
larger in restenotic specimens from patients with DM than in restenotic specimens from
patients without DM (77 6 9% vs. 53 6 4%; p 5 0.004). The percentages of atheroma and
thrombus were similar in both groups.
CONCLUSIONS Intimal hypercellular tissue content is reduced in restenotic tissue from patients with DM.
Collagen-rich sclerotic content is increased in restenotic lesions from patients with DM.
These results suggest an accelerated fibrotic rather than a proliferative response in diabetic
lesions from patients with restenosis after PTCA. (J Am Coll Cardiol 1999;34:1045–9) ©
1999 by the American College of Cardiology
Coronary artery disease causes 75% of all deaths in patients
with either insulin-dependent or non–insulin-dependent
diabetes mellitus (DM) (1). Percutaneous transluminal cor-
onary angioplasty (PTCA) has an increased morbidity and
mortality in patients with DM (2). Furthermore, diabetes is
an independent risk factor for restenosis after PTCA (2). In
addition, five-year survival is significantly lower among
diabetic patients undergoing multiple vessel PTCA than
among diabetic patients undergoing surgical revasculariza-
tion (3). Diabetes has been associated with increased ex-
pression and activity of growth factors that may lead to an
exaggerated intimal hyperplastic response (4). Intravascular
ultrasound at the time of intervention suggests that the
predominant mechanism of restenosis is intimal thickening,
supporting an increased hypercellular response in patients
with DM (5). Despite these observations, histologic analysis
of restenotic coronary lesions from patients with DM has
not been reported. This study was designed to test the
hypothesis that hypercellular tissue content was increased in
coronary restenotic plaque tissue from patients with DM in
comparison with patients without DM.
METHODS
Patient group. From October 1990 to October 1995, 80
consecutive directional coronary atherectomy (DCA) pro-
cedures were performed for symptomatic coronary resteno-
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sis after PTCA in the Cardiac Catheterization Laboratory
of the Massachusetts General Hospital. Of these 80 proce-
dures, 20 were performed in patients with DM and 60 in
patients without DM. Restenosis was defined as percent
diameter stenosis .50% by coronary angiography at the
time of restudy. Eighteen consecutive DCA specimens from
the diabetic group were analyzed and comprise the study
group. Diabetes was defined as a fasting blood glucose level
.140 mg/dl. All diabetic patients were known diabetics
(mean duration 8 6 4 years) at the time of the intervention.
Three patients were taking insulin, five were taking sulfo-
nylurea medication, one patient was taking a combination of
sulfonylurea and glucophage and 11 patients were on a diet.
Eighteen DCA specimens from nondiabetic patients
matched by the time of restenosis were analyzed and were in
the control group. Specimens from saphenous vein grafts
were excluded.
Quantitative measurement of coronary stenosis. An-
giography was performed before and immediately after
DCA using the same single-view projections and angulation
as shown in Table 2. Reference diameter, percent diameter
stenosis and minimal lumen diameter were determined by
quantitative coronary analysis after intracoronary adminis-
tration of 100 mg of nitroglycerin, using a computer-assisted
automated edge detection algorithm (Computer Measure-
ments Systems, MEDIS, Nuenen, The Netherlands) (6).
Atherectomy specimen. Multiple pieces of tissue were
obtained from each lesion and immediately immersion-fixed
in 10% buffered formalin. Tissue was processed for paraffin
embedding. Sections were cut at 5 mm and stained by the
combined Masson elastic method.
Morphometry. The combined Masson elastic stain was
used to identify and quantify coronary tissue components, as
previously reported (7). Briefly, hypercellular tissue is com-
posed of loose connective tissue matrix containing numer-
ous stellate cells; collagen-rich sclerotic tissue is composed
of tissue with scant cells and densely stained collagen;
atheromatous gruel is composed of acellular debris with
cholesterol clefts; and thrombus is composed of red blood
cells and fibrin. Each specimen’s areas were outlined at low
magnification (340) and quantified by manual planimetry.
Statistical analysis. Results are expressed as the mean
value 6 SEM. P values ,0.05 are considered statistically
significant. For comparison of discrete variables the Fisher
exact test was used. For comparison of two gaussian sam-
ples, the two-tailed Student t test was used.
RESULTS
Clinical, demographic and angiographic data. There
were no significant differences between the two groups with
regard to age, gender, hypercholesterolemia, hypertension,
cigarette smoking and family history of coronary artery
disease (Table 1). The artery containing the culprit lesion
was similar in both groups. In the diabetic group, the culprit
lesion was located in the left anterior descending coronary
artery (LAD) in nine patients, in the right coronary artery
(RCA) in five patients and in the left circumflex coronary
artery (LCx) in four patients. In the nondiabetic group, the
culprit lesion was located in the LAD in eight patients, in
the RCA in five patients and in the LCx in five patients
(p 5 NS for all comparisons). The incidence of first
restenosis was 89% in the diabetic group and 78% in the
nondiabetic group (p 5 NS). The reference diameter,
percent diameter stenosis and minimal lumen diameter at
the time of DCA were similar for both groups (Table 2).
The number of vessels with stenosis .50%, the number of
pieces of tissue and the number of cuts performed with the
DCA catheter were also similar in both groups (Table 2).
Morphometry data. The total area and the areas of each of
the plaque components are given in Table 3. The percent
total area occupied by hypercellular tissue was significantly
lower in samples from patients with DM than in samples
from patients without DM (p 5 0.003). The area occupied
by collagen-rich sclerotic tissue was significantly larger in
samples from patients with DM than in samples from
patients without DM (p 5 0.004). Areas of atheromatous
tissue and thrombus were similar both groups. Atheroma-
Abbreviations and Acronyms
DCA 5 directional coronary atherectomy
DM 5 diabetes mellitus
LAD 5 left anterior descending coronary artery
LCx 5 left circumflex coronary artery
PTCA 5 percutaneous transluminal coronary angioplasty
RCA 5 right coronary artery
Table 1. Clinical and Demographic Data of Patients With
Diabetes Mellitus Versus Patients Without Diabetes Mellitus
With Restenosis After Successful Coronary Atherectomy
Patients
With
Diabetes
(n 5 18)
Patients
Without
Diabetes
(n 5 18)
p
Value
Age (yr) 64 6 9 63 6 13 0.93
Female 6 (33%) 3 (18%) 0.22
Coronary risk factors
Hypercholesterolemia 11 (61%) 12 (67%) 1.00
Hypertension 12 (67%) 14 (78%) 0.35
Smoker 7 (39%) 10 (56%) 0.25
Family history 4 (22%) 8 (44%) 0.14
Symptoms
Stable angina 2 (11%) 6 (33%) 0.22
Unstable angina 12 (67%) 11 (61%) 1.00
Acute non–Q wave MI 3 (17%) 0 (0%) 0.23
Congestive heart failure 3 (17%) 1 (6%) 0.60
Data are presented as mean value 6 SEM or number (%) of patients.
MI 5 myocardial infarction.
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tous core was present in 4 of the 18 samples from patients
with DM and in 1 of the 18 samples from patients without
DM (p 5 NS). Thrombus was present in 6 of the 18
samples from patients with DM and in 7 of the 18 samples
from patients without DM (p 5 NS).
To identify possible differences in coronary plaque com-
position among diabetic patients with or without pharma-
cologic therapy, a subgroup analysis was performed (Table
4). There were no significant differences in total area,
hypercellular tissue, collagen-rich sclerotic tissue, atheroma-
tous tissue or thrombus between diabetic patients treated
with insulin or oral hypoglycemic medication and diabetic
patients treated with diet alone.
DISCUSSION
The major findings of this study reveal that hypercellular
tissue is reduced in coronary restenotic specimens from
patients with DM compared with coronary restenotic spec-
imens from patients without DM. Furthermore, areas
composed of collagen-rich sclerotic tissue are increased in
restenotic tissue from patients with DM. Diabetic patients
with or without pharmacologic therapy have a higher
incidence of myocardial infarction and a greater need for
additional revascularization procedures than patients with-
out DM (8). This study included patients with either
insulin, oral hyploglycemic medication or diet. In an effort
to establish differences in coronary tissue composition be-
tween patients with or without pharmacologic therapy, a
subgroup analysis was performed. There were no significant
differences in coronary tissue composition between diabetics
taking either insulin or oral hypoglycemic therapy and
diabetics on diet alone.
Experimental and clinical studies have demonstrated that
the contribution of smooth muscle cell proliferation to
restenosis after PTCA is limited, and lumen renarrowing is
predominately related to vessel remodeling (9,10). In con-
trast, in-stent restenotic tissue analysis reveals abundant
smooth muscle cell proliferation (11). Diabetes is an inde-
pendent predictor for restenosis after PTCA, so balloon
angioplasty in diabetic patients with multivessel coronary
artery disease has been seriously questioned (12). However,
there are conflicting reports regarding restenosis after cor-
onary stents in diabetic patients. Carrozza et al. (13)
demonstrated an enhanced late loss and a higher rate of
restenosis in diabetic patients. More recently, Elezi et al.
(14) followed diabetic patients with or without pharmaco-
Table 3. Total and Segmental Areas of Coronary Restenotic Tissue From Patients With
Diabetes Mellitus Versus Patients Without Diabetes Mellitus
Patients With
Diabetes
(n 5 18)
Patients Without
Diabetes
(n 5 18)
p
Valuemm2 (%) mm2 (%)
Total area 4.16 6 0.9 100 4.14 6 0.6 100 0.89
Hypercellular tissue 1.17 6 0.5 19 6 6 1.99 6 0.4 43 6 5 0.003
Collagen-sclerotic tissue 2.89 6 0.5 77 6 9 1.95 6 0.3 53 6 4 0.004
Atheromatous core 0.07 6 0.07 3 6 3 0.01 6 0.01 0.2 6 0.2 0.64
Thrombus 0.03 6 0.01 1 6 3 0.19 6 0.04 3 6 1 0.84
Data are presented as mean value 6 SEM.
Table 2. Angiographic and Procedural Data of Patients With Diabetes Mellitus Versus Patients
Without Diabetes Mellitus With Restenosis After Successful Coronary Atherectomy
Patients With
Diabetes (n 5 18)
Patients Without
Diabetes (n 5 18)
p
Value
Angiographic data
Reference diameter (mm) 3.5 6 0.5 3.2 6 0.5 0.32
MLD before DCA (mm) 0.89 6 0.48 0.93 6 0.32 0.75
Stenosis before DCA 71 6 14% 73 6 10% 0.75
MLD after DCA (mm) 3.05 6 0.07 2.5 6 0.5 0.18
Stenosis after DCA 15 6 8% 16 6 9% 0.55
Interval (weeks)* 14 6 4 14 6 4 1.00
No. of vessels† 2.05 6 0.9 1.66 6 0.8 0.16
Pieces per sample 13 6 5 16 6 3 0.33
DCA French size 6.75 6 0.5 6.50 6 0.6 0.54
*Interval between percutaneous transluminal coronary angioplasty for a primary lesion and atherectomy for a restenotic lesion.
†Coronary disease .50% by angiography. Data are presented as mean value 6 SEM.
DCA 5 directional coronary atherectomy; MLD 5 minimal lumen diameter.
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logic therapy after coronary stenting and compared them
with nondiabetic patients. In-stent restenosis was found to
be significantly higher in diabetic patients. In contrast, two
studies failed to identify diabetes as an independent risk
factor for restenosis after coronary stenting (15,16). Fur-
thermore, Van Belle et al. (17) provided evidence that
diabetic patients do not have an increased rate of restenosis
after coronary stenting in comparison with nondiabetic
patients. The results of this study support the findings of a
predominant collagen-mediated sclerotic reaction instead of
an exaggerated hyperplastic response as the main mecha-
nism of restenosis after PTCA in patients with DM. Elastic
recoil may play a role in restenosis after PTCA in diabetic
patients. Using quantified planimetry on coronary atherec-
tomy specimens from patients with early loss after PTCA,
we have recently shown that lesions undergoing elastic recoil
are predominately composed of collagen-rich sclerotic tissue
(18). Arterial wall collagen in diabetic patients has a
fourfold greater content of advanced glycosylation end
products than in nondiabetic patients (19). Specific recep-
tors for proteins modified by advanced glycosylation end
products have been identified in both monocytes/
macrophages and endothelial cells (20). Our laboratory has
recently identified an increased content of macrophages in
coronary tissue from patients with DM (21). Considering
that macrophage content is an independent predictor of
restenosis after percutaneous intervention (22), this interac-
tion may play a role in the pathophysiology of restenosis
after PTCA in diabetic patients. Finally, an accelerated
transformation of hypercellular tissue into mature collagen
in restenotic tissue from diabetics should be considered. We
matched the control group by the time of restenosis.
However, with a more rapid response, diabetics may have
similar cellular changes as nondiabetics, but just earlier.
Further studies should be performed to resolve this ques-
tion.
Study limitations. Smooth muscle cell proliferation should
be evaluated by specific proliferation assays and not by
quantified planimetry. However, this is not a study of
smooth muscle cell proliferation. In contrast, comparison of
intimal hyperplastic areas (mm2) are properly evaluated by
quantified planimetry. Directional coronary atherectomy is
able to extract only 33% of the plaque in primary lesions, so
histologic analysis may not reflect total plaque composition
(23). However, it is a unique technique to obtain human
coronary tissue in vivo. To diminish the possibility of a
selection bias, we compared clinical, angiographic, proce-
dural and histologic variables in both groups. There were no
significant differences in any of these variables between the
two groups, diminishing the risk of a selection bias. Finally,
the subgroup analysis does not have enough power to
identify tissue differences in diabetics treated with medica-
tions, insulin or diet alone. More information is required to
completely elucidate this issue.
Conclusions. Intimal hypercellular tissue content is re-
duced in restenotic tissue from patients with DM.
Collagen-rich sclerotic content is increased in restenotic
lesions from patients with DM. These results suggest an
accelerated fibrotic rather than a proliferative response in
diabetic lesions from patients with restenosis after PTCA.
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